این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Research in Medical Sciences، جلد ۲۷، شماره ۱۹، صفحات ۲۰۲۲-۲۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double?blind clinical trial
چکیده انگلیسی مقاله Background: A large liver size is a factor that may increase the difficulty of bariatric surgery (BS) and unwanted complications. Some agents have been used to decrease the liver size before BS. Silymarin has been used as an antioxidant agent to improve liver function tests. This study was designed to evaluate the effects of silymarin on liver dimensions, function, and lipid profile. Materials and Methods: A double?blind randomized clinical trial was performed on 56 patients. The patients were divided into silymarin and placebo groups. Blood samples and sonographic examinations were taken from the patients before and 4 weeks after the administration of the silymarin or placebo. In the first group, 140 mg silymarin was prescribed every 8 h for 4 weeks, and the other group received placebo in the same way with the same tablet hape. After the completion of the 4?week treatment, laboratory tests and ultrasonography were carried out again. Results: Thirty?nine (69.6%) atients were female with a mean body mass index (BMI) of 46.2 kg/m2 and a mean age of 36.8 years. Most of the patients had a compliance of 80% and higher. The analysis did not show any significant difference in aspartate transaminase, alkaline transaminase, liver size, cholesterol, and triglyceride changes among the silymarin and placebo groups. BMI loss was slightly higher in the silymarin group although the difference was not statistically significant. Conclusion: The present findings show that silymarin administration for 4 weeks does not affect liver size and unction, but further evaluations should be carried out on the subject.
کلیدواژه‌های انگلیسی مقاله Clinical trial, liver size, morbid obesity, nonalcoholic fatty liver disease, silymarin, ultrasound
نویسندگان مقاله | Hamed Atarodi


| Abdolreza Pazouki


| Barmak Gholizadeh


| Reza Karami


| Ali Kabir


| Ghazal Sadri


| Radwan Kassir


| Mohammad Kermansaravi


نشانی اینترنتی http://jrms.mui.ac.ir/index.php/jrms/article/view/11385
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات